A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors
Clinical trial NCT06873542 · COMPLETED
Trial details
- NCT number
- NCT06873542
- Sponsor
- Heronova Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2022-12-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.